Clinical trialNCT00751530CompletedObservational

BRAVO: Background Regimen of Raltegravir on Virologic Outcome

SponsorCommunity Research Initiative of New EnglandEnrollment442HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a retrospective chart review of participants in raltegravir expanded access program and will compare virologic response in regimens not containing a protease inhibitor in the antiretroviral background regimen to regimens containing a protease inhibitor in the background regimen.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel Skiest, MD
Community Research Initiative
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Aids Healthcare Foundation
Los Angeles, California, United States
Light Source Medical
Los Angeles, California, United States
Synergy Hematology and Oncology
Los Angeles, California, United States
Quest Clinical Research
San Francisco, California, United States
Connecticut Health Care Group
Glastonbury, Connecticut, United States
Capital Medical Associates Pc
Washington D.C., District of Columbia, United States
Dupont Circle Physicians Group
Washington D.C., District of Columbia, United States
Orlando Immunology Center
Orlando, Florida, United States
Ruth M. Rothstein Core Center
Chicago, Illinois, United States
Community Research Initiative
Boston, Massachusetts, United States
Community Research Initiative - West
Springfield, Massachusetts, United States
Infectious Diseases and Hiv Medicine Immunodeficiency Clinic
Buffalo, New York, United States
Bellman, Md
New York, New York, United States
Mounzer, Md
Philadelphia, Pennsylvania, United States
Dr. Nicholaos C. Bellos & Associates
Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Raltegravir →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Mar 2008
Primary completion: 15 Jun 2009
Completion: 15 Jun 2009
Last update posted: 2 Jul 2017
Registered enrollment: 442
Registry id: NCT00751530

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.